Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Huapont Life Science Co's Days Sales Outstanding for the
three
months ended in Jun. 2026 was 85.954.
Huapont Life Science Co's Days Inventory for the
three
months ended in Jun. 2026 was 94.502.
Huapont Life Science Co's Days Payable for the
three
months ended in Jun. 2026 was 52.785.
Therefore, Huapont Life Science Co's Cash Conversion Cycle (CCC) for the
three
months ended in Jun. 2026 was 127.67.
Huapont Life Science Co (SZSE:002004) Cash Conversion Cycle Explanation
Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.
Be Aware
CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.
The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.
Huapont Life Science Co Cash Conversion Cycle Related Terms
Huapont Life Science Co Cash Conversion Cycle Historical Data
* Premium members only.
The historical data trend for Huapont Life Science Co's Cash Conversion Cycle can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Huapont Life Science Co Cash Conversion Cycle Chart
SZSE:002004 vs CTVA, CF, MOS: Cash Conversion Cycle Comparison
For the Agricultural Inputs subindustry, Huapont Life Science Co's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Huapont Life Science Co Cash Conversion Cycle vs Agriculture Industry
For the Agriculture industry and Basic Materials sector, Huapont Life Science Co's Cash Conversion Cycle distribution charts can be found below:
* The bar in red indicates where Huapont Life Science Co's Cash Conversion Cycle falls into.
Huapont Life Science Co Cash Conversion Cycle Calculation
Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.
Cash Conversion Cycle is one of several measures of management effectiveness.
Huapont Life Science Co's Cash Conversion Cycle for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Huapont Life Science Co (SZSE:002004) has a Cash Conversion Cycle of 127.67 as of Jun. 2026. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on Huapont Life Science Co and its competitors.
Is Huapont Life Science Co's Cash Conversion Cycle too high?
Huapont Life Science Co's current Cash Conversion Cycle is 127.67. The Agriculture industry median Cash Conversion Cycle is 102.87. Huapont Life Science Co's value of 127.67 is 24.1% above this industry median. Overall, Huapont Life Science Co has a GF Score™ of 65/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Huapont Life Science Co's Cash Conversion Cycle compare to CTVA and CF?
Huapont Life Science Co's Cash Conversion Cycle of 127.67 can be compared against companies in the Agriculture industry. The industry median Cash Conversion Cycle is 102.87. Huapont Life Science Co's value of 127.67 is 24.1% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Conversion Cycle for an Agriculture company?
The median Cash Conversion Cycle among Agriculture companies is 102.87, based on 252 companies in the industry. Companies in the top quartile (top 25%) have a Cash Conversion Cycle significantly above this median, while those in the bottom quartile fall well below. However, Cash Conversion Cycle should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Huapont Life Science Co's current Cash Conversion Cycle of 127.67 is 24.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Conversion Cycle mean?
A high Cash Conversion Cycle can signal that a stock is expensive relative to its fundamentals. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on Huapont Life Science Co and its competitors. For the Agriculture industry, the median Cash Conversion Cycle is 102.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Huapont Life Science Co's current Cash Conversion Cycle is 127.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Huapont Life Science Co stock overvalued right now?
Based on GuruFocus' analysis, Huapont Life Science Co (SZSE:002004) is currently considered Fairly Valued. The stock's GF Value™ is ¥4.43, compared to a current price of ¥4.38 — trading 1.1% below its estimated fair value. The current Cash Conversion Cycle is 127.67 and 24.1% above the Agriculture industry median of 102.87. Huapont Life Science Co's overall GF Score™ is 65/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Conversion Cycle calculated?
Cash Conversion Cycle is calculated from a company's financial statements. For Huapont Life Science Co (SZSE:002004), the current Cash Conversion Cycle is 127.67 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Huapont Life Science Co (SZSE:002004) Overvalued in 2026?
Based on GuruFocus' analysis, Huapont Life Science Co stock appears to be undervalued.
The current stock price of ¥4.38 is trading 1.1% below its estimated GF Value™ of ¥4.43.
GuruFocus considers Huapont Life Science Co to be Fairly Valued.
Key valuation signals for SZSE:002004:
Cash Conversion Cycle: 127.67
GF Value™: ¥4.43 vs. price of ¥4.38 (1.1% below fair value)
Industry Position: 24.1% above the Agriculture median
No single metric tells the full story. See the SZSE:002004 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Huapont Life Science Co Ltd is a China-based company engaged in the manufacturing and distribution of pharmaceutical products. In addition, the company is also engaged in the agrochemical business and medical business. The agrochemical department is mainly engaged in the research and development, production, sales, and technical services of pesticide intermediates, original drugs, and preparations.
65GF Score
Get the complete analysis for SZSE:002004
Cash Conversion Cycle is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SZSE:002004 has been successfully added to your 
